ReviewCurrent oncology reports2021

Epigenetics of Indolent Lymphoma and How It Drives Novel Therapeutic Approaches-Focus on EZH2-Targeted Drugs.

Jemma Longley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.